Richard J. Meelia's most recent trade in Conformis Inc. was a trade of 122,223 Common Stock done . Disclosure was reported to the exchange on June 4, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conformis Inc. | Richard J. Meelia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 122,223 | 122,223 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp | Richard J. Meelia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.50 per share. | 04 Feb 2021 | 10,353 | 42,403 (0%) | 0% | 35.5 | 367,557 | Common Stock |
| Haemonetics Corp | Richard J. Meelia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 10,353 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp | Richard J. Meelia | Director | Sale of securities on an exchange or to another person at price $ 134.64 per share. | 04 Feb 2021 | 10,353 | 32,050 (0%) | 0% | 134.6 | 1,393,928 | Common Stock |